Adicet Bio Inc
NASDAQ:ACET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
Intrinsic Value
The intrinsic value of Adicet Bio Inc (ACET) under the Base Case is 13.97 USD per share.
Compared with the current market price of 5.14 USD, the stock appears
Undervalued by 63% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Adicet Bio Does
Adicet Bio is a clinical-stage biotechnology company that develops cell therapies made from donor immune cells, especially gamma delta T cells. Its goal is to create “off-the-shelf” treatments that can be given to patients without having to collect and engineer each patient’s own cells. The company’s main work is research and development of these therapies for cancers and, more recently, autoimmune diseases.
- Headquarters
- United States of America US
- Employees
- 102
- IPO date
- Jan 26, 2018
Revenue & Expenses Breakdown
Adicet Bio Inc
Earnings Waterfall
Adicet Bio Inc
The intrinsic value for Adicet Bio Inc (ACET) under the Base Case is 13.97 USD.
Compared with the current market price of 5.14 USD, the stock appears Undervalued by 63% .